A carregar...
Durable response to nivolumab in a lung adenocarcinoma patient with idiopathic pulmonary fibrosis
The efficacy and safety of immune‐checkpoint inhibitors in non‐small cell lung cancer patients with idiopathic pulmonary fibrosis (IPF) remain unknown. Herein, we describe the case of a 62‐year‐old man with multiple pleural tumors and carcinomatous pleurisy. High‐resolution computed tomography indic...
Na minha lista:
| Publicado no: | Thorac Cancer |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley & Sons Australia, Ltd
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6209776/ https://ncbi.nlm.nih.gov/pubmed/30152594 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.12853 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|